Changes in tissue fatty acid composition in murine malignancy and following anticancer therapy

Area of Science:

• Biochemistry
• Oncology
• Pharmacology

Background:

• Tumorigenesis is associated with altered lipid metabolism.
• Fatty acids (FAs) play crucial roles in cellular processes and disease progression.
• Understanding FA profiles in tumors and host tissues is vital for therapeutic strategies.

Purpose of the Study:

• To analyze the fatty acid composition of a mouse mammary adenocarcinoma (NC tumour) and associated normal tissues.
• To investigate the effects of methotrexate (MTX) and indomethacin (INDO) on FA profiles in tumor-bearing mice.
• To explore potential MTX potentiation by INDO in modulating FA metabolism.

Main Methods:

• Quantification of 17 fatty acids and their ratios in tumor, mammary tissue, spleen, liver, and plasma.
• Administration of vehicle control, indomethacin (1.25 mg/kg), methotrexate (2 or 4 mg/kg), or combination treatments.
• Comparative analysis of FA profiles between treatment groups and control.

Main Results:

• NC tumors exhibited altered FA composition compared to normal mammary tissue.
• Tumor-bearing mice showed changes in FA levels in spleen, liver, and plasma.
• MTX treatment partially restored tumor FA profiles and reduced the saturated/unsaturated FA ratio.
• INDO alone affected normal mammary tissue FAs but had limited impact on other tissues.
• No significant evidence of MTX potentiation by INDO was observed.

Conclusions:

• Fatty acid dysregulation is a hallmark of NC tumors and affects host tissues.
• MTX demonstrates potential in normalizing tumor FA composition.
• INDO does not appear to potentiate MTX's effects on FA metabolism in this model.
• Findings provide insights into cancer-associated metabolic changes and treatment responses.